Carcinoid heart disease: Case and literature review

被引:12
作者
Dumoulein, Michiel [1 ]
Verslype, Chris [2 ]
Van Cutsem, Eric [2 ]
Meuris, Bart [3 ]
Herijgers, Paul [3 ]
Flameng, Willem [3 ]
Herregods, Marie-Christine [1 ]
机构
[1] UZ Leuven, Dept Cardiol, B-3000 Louvain, Belgium
[2] UZ Leuven, Dept Digest Oncol, B-3000 Louvain, Belgium
[3] UZ Leuven, Dept Cardiac Surg, B-3000 Louvain, Belgium
关键词
Neuroendocrine tumour; carcinoid syndrome; tricuspid regurgitation; heart failure; DOPAMINE AGONISTS; PROGNOSIS;
D O I
10.2143/AC.65.2.2047065
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We present the case of a 69-year-old woman with a metastatic neuroendocrine tumour of the ileum and severe tricuspid valve regurgitation due to carcinoid valvulopathy. Carcinoid heart disease arises in the context of metastatic serotonin-producing neuroendocrine tumours and typically presents as structural and functional abnormalities of tricuspid (TV) or pulmonary valve (PV). Carcinoid heart disease arises from a low-grade neuroendocrine tumour derived from serotonin-producing enterochromaffin cells that reduces the mobility of the leaflets. Following the development of this type of heart failure, the prognosis is unfavourable and patients usually die as a result of heart failure and not because of the metastatic disease. Our patient was not considered a candidate for valvular surgery because of the progressive nature of the malignancy. However, surgical valve replacement is a therapeutic option that, although it has a significant mortality, needs to be considered in selected patients and leads to improvement in functional capacity and survival.
引用
收藏
页码:261 / 264
页数:4
相关论文
共 20 条
[1]  
Connolly HM, 2001, CIRCULATION, V104, pI36
[2]   OUTCOME OF CARDIAC-SURGERY FOR CARCINOID HEART-DISEASE [J].
CONNOLLY, HM ;
NISHIMURA, RA ;
SMITH, HC ;
PELLIKKA, PA ;
MULLANY, CJ ;
KVOLS, LK .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (02) :410-416
[3]   Valvular heart disease associated with fenfluramine-phentermine [J].
Connolly, HM ;
Crary, JL ;
McGoon, MD ;
Hensrud, DD ;
Edwards, BS ;
Edwards, WD ;
Schaff, HV .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (09) :581-588
[4]   Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease [J].
Denney, WD ;
Kemp, WE ;
Anthony, LB ;
Oates, JA ;
Byrd, BF .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (04) :1017-1022
[5]   Carcinoid heart disease: Presentation, diagnosis, and management [J].
Fox, DJ ;
Khattar, RS .
HEART, 2004, 90 (10) :1224-1228
[6]   Long-term serotonin administration induces heart valve disease in rats [J].
Gustafsson, BI ;
Tommerås, K ;
Nordrum, I ;
Loennechen, JP ;
Brunsvik, A ;
Solligård, E ;
Fossmark, R ;
Bakke, I ;
Syversen, U ;
Waldum, H .
CIRCULATION, 2005, 111 (12) :1517-1522
[7]   CARCINOID HEART-DISEASE - RELATIONSHIP OF CIRCULATING VASOACTIVE SUBSTANCES TO ULTRASOUND-DETECTABLE CARDIAC ABNORMALITIES [J].
LUNDIN, L ;
NORHEIM, I ;
LANDELIUS, J ;
OBERG, K ;
THEODORSSONNORHEIM, E .
CIRCULATION, 1988, 77 (02) :264-269
[8]  
Modlin IM, 1997, CANCER-AM CANCER SOC, V79, P813, DOI 10.1002/(SICI)1097-0142(19970215)79:4<813::AID-CNCR19>3.0.CO
[9]  
2-2
[10]   Prognosis of carcinoid heart disease - Analysis of 200 cases over two decades [J].
Moller, JE ;
Pellikka, PA ;
Bernheim, AM ;
Schaff, HV ;
Rubin, J ;
Connolly, HM .
CIRCULATION, 2005, 112 (21) :3320-3327